DPP4-inhibitor improves neuronal insulin receptor function, Brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption

European Journal of Neuroscience

Volumn 37, Issue 5, 2013, Pages 839-849

  Pipatpiboon, Noppamas ^a   Pintana, Hiranya ^a   Pratchayasakul, Wasana ^a   Chattipakorn, Nipon ^a,b   Chattipakorn, Siriporn C ^a,b  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Brain mitochondria; Cognition; FEPSP; High fat diet; Neuronal insulin resistance; Vildagliptin

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; INSULIN RECEPTOR; VILDAGLIPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; BRAIN SLICE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEARNING DISORDER; LIPID DIET; LONG TERM DEPRESSION; MALE; MAZE TEST; MEMORY DISORDER; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT;

ADAMANTANE; ANIMALS; BRAIN; COGNITION; DIET, HIGH-FAT; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; GENE EXPRESSION; GLUCAGON-LIKE PEPTIDE 1; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LONG-TERM SYNAPTIC DEPRESSION; MALE; MAZE LEARNING; MEMBRANE POTENTIAL, MITOCHONDRIAL; MEMORY; MITOCHONDRIA; NEURONS; NITRILES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTOR, INSULIN;

EID: 84874525661     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.12088     Document Type: Article

References (57)

1. Abbas, T., Faivre, E. & Holscher, C. (2009) Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: interaction between type 2 diabetes and Alzheimer's disease. Behav. Brain Res., 205, 265-271.
2. Acitores, A., Gonzalez, N., Sancho, V., Valverde, I. & Villanueva-Penacarrillo, M.L. (2004) Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle. J. Endocrinol., 180, 389-398.
3. Agrawal, R., Tyagi, E., Shukla, R. & Nath, C. (2011) Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model. Eur. Neuropsychopharmacol., 21, 261-273.
4. Akarte, A.S., Srinivasan, B.P. & Gandhi, S. (2011) A novel long acting DPP-IV inhibitor PKF-275-055 stimulates beta-cell proliferation resulting in improved glucose homeostasis in diabetic rats. Biochem. Pharmacol., 83, 241-252.
5. Apaijai, N., Pintana, H., Chattipakorn, S.C. & Chattipakorn, N. (2012) Cardioprotective effects of metformin and vildagliptin in adult rats with insulin resistance induced by a high-fat diet. Endocrinology, 153, 3878-3885.
6. Arakawa, H. (2005) Age dependent effects of space limitation and social tension on open-field behavior in male rats. Physiol. Behav., 84, 429-436.
7. Boschmann, M., Engeli, S., Dobberstein, K., Budziarek, P., Strauss, A., Boehnke, J., Sweep, F.C., Luft, F.C., He, Y., Foley, J.E. & Jordan, J. (2009) Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients. J. Clin. Endocrinol. Metab., 94, 846-852.
8. Burkey, B.F., Li, X., Bolognese, L., Balkan, B., Mone, M., Russell, M., Hughes, T.E. & Wang, P.R. (2005) Acute and chronic effects of the incretin enhancer vildagliptin in insulin-resistant rats. J. Pharmacol. Exp. Ther., 315, 688-695.
9. Chen, S., Liu, A.R., An, F.M., Yao, W.B. & Gao, X.D. (2011) Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4. Age (Dordr), 34, 1211-1224.
10. Craft, S. (2005) Insulin resistance syndrome and Alzheimer's disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol. Aging, 26(Suppl 1), 65-69.
11. Craft, S. (2007) Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment. Curr. Alzheimer Res., 4, 147-152.
12. Craft, S. & Watson, G.S. (2004) Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol., 3, 169-178.
13. Davidson, J.A., Parente, E.B. & Gross, J.L. (2008) Incretin mimetics and dipeptidyl peptidase-4 inhibitors: innovative treatment therapies for type 2 diabetes. Arq. Bras. Endocrinol. Metabol., 52, 1039-1049.
14. Dou, J.T., Chen, M., Dufour, F., Alkon, D.L. & Zhao, W.Q. (2005) Insulin receptor signaling in long-term memory consolidation following spatial learning. Learn Mem., 12, 646-655.
15. Doupis, J. & Veves, A. (2008) DPP4 inhibitors: a new approach in diabetes treatment. Adv. Ther., 25, 627-643.
16. Drucker, D.J. & Nauck, M.A. (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet, 368, 1696-1705.
17. Dunphy, J.L., Taylor, R.G. & Fuller, P.J. (1998) Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression. Mol. Cell. Endocrinol., 141, 179-186.
18. During, M.J., Cao, L., Zuzga, D.S., Francis, J.S., Fitzsimons, H.L., Jiao, X., Bland, R.J., Klugmann, M., Banks, W.A., Drucker, D.J. & Haile, C.N. (2003) Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat. Med., 9, 1173-1179.
19. Ferreira, L., Teixeira-de-Lemos, E., Pinto, F., Parada, B., Mega, C., Vala, H., Pinto, R., Garrido, P., Sereno, J., Fernandes, R., Santos, P., Velada, I., Melo, A., Nunes, S., Teixeira, F. & Reis, F. (2010) Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat). Mediators Inflamm., 2010, 592760.
20. Flock, G., Baggio, L.L., Longuet, C. & Drucker, D.J. (2007) Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice. Diabetes, 56, 3006-3013.
21. Gallwitz, B. (2006) Therapies for the treatment of type 2 diabetes mellitus based on incretin action. Minerva Endocrinol., 31, 133-147.
22. Gault, V.A. & Holscher, C. (2008) GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. Eur. J. Pharmacol., 587, 112-117.
23. Gonzalez, N., Acitores, A., Sancho, V., Valverde, I. & Villanueva-Penacarrillo, M.L. (2005) Effect of GLP-1 on glucose transport and its cell signalling in human myocytes. Regul. Pept., 126, 203-211.
24. Guo, L. & Tabrizchi, R. (2006) Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance. Pharmacol. Ther., 111, 145-173.
25. van der Heide, L.P., Kamal, A., Artola, A., Gispen, W.H. & Ramakers, G.M. (2005) Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J. Neurochem., 94, 1158-1166.
26. Heijboer, A.C., Frans, A., Lomecky, M. & Blankenstein, M.A. (2011) Analysis of glucagon-like peptide 1; what to measure? Clin. Chim. Acta, 412, 1191-1194.
27. Huang, C.C., You, J.L., Lee, C.C. & Hsu, K.S. (2003) Insulin induces a novel form of postsynaptic mossy fiber long-term depression in the hippocampus. Mol. Cell. Neurosci., 24, 831-841.
28. Jin, H.Y., Liu, W.J., Park, J.H., Baek, H.S. & Park, T.S. (2009) Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats. Arch. Med. Res., 40, 536-544.
29. Kastin, A.J., Akerstrom, V. & Pan, W. (2002) Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J. Mol. Neurosci., 18, 7-14.
30. Knauf, C., Cani, P.D., Ait-Belgnaoui, A., Benani, A., Dray, C., Cabou, C., Colom, A., Uldry, M., Rastrelli, S., Sabatier, E., Godet, N., Waget, A., Penicaud, L., Valet, P. & Burcelin, R. (2008) Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure. Endocrinology, 149, 4768-4777.
31. Levy, M., Faas, G.C., Saggau, P., Craigen, W.J. & Sweatt, J.D. (2003) Mitochondrial regulation of synaptic plasticity in the hippocampus. J. Biol. Chem., 278, 17727-17734.
32. Li, Y., Duffy, K.B., Ottinger, M.A., Ray, B., Bailey, J.A., Holloway, H.W., Tweedie, D., Perry, T., Mattson, M.P., Kapogiannis, D., Sambamurti, K., Lahiri, D.K. & Greig, N.H. (2011) GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease. J. Alzheimers Dis., 19, 1205-1219.
33. Liu, X., Harada, N., Yamane, S., Kitajima, L., Uchida, S., Hamasaki, A., Mukai, E., Toyoda, K., Yamada, C., Yamada, Y., Seino, Y. & Inagaki, N. (2009) Effects of long-term dipeptidyl peptidase-IV inhibition on body composition and glucose tolerance in high fat diet-fed mice. Life Sci., 84, 876-881.
34. Lundbaek, K. (1962) Intravenous glucose tolerance as a tool in definition and diagnosis of diabetes mellitus. Br. Med. J., 1, 1507-1513.
35. McClean, P.L., Gault, V.A., Harriott, P. & Holscher, C. (2010) Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease. Eur. J. Pharmacol., 630, 158-162.
36. McNay, E.C. & Recknagel, A.K. (2011) Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes. Neurobiol. Learn. Mem., 96, 432-442.
37. McNeilly, A.D., Williamson, R., Balfour, D.J., Stewart, C.A. & Sutherland, C. (2012) A high-fat-diet-induced cognitive deficit in rats that is not prevented by improving insulin sensitivity with metformin. Diabetologia, 55, 3061-3070.
38. Mielke, J.G., Taghibiglou, C., Liu, L., Zhang, Y., Jia, Z., Adeli, K. & Wang, Y.T. (2005) A biochemical and functional characterization of diet-induced brain insulin resistance. J. Neurochem., 93, 1568-1578.
39. Nauck, M.A. & Meier, J.J. (2005) Glucagon-like peptide 1 and its derivatives in the treatment of diabetes. Regul. Pept., 128, 135-148.
40. Oeseburg, H., de Boer, R.A., Buikema, H., van der Harst, P., van Gilst, W.H. & Sillje, H.H. (2010) Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Arterioscler. Thromb. Vasc. Biol., 30, 1407-1414.
41. Perlmuter, L.C., Nathan, D.M., Goldfinger, S.H., Russo, P.A., Yates, J. & Larkin, M. (1988) Triglyceride levels affect cognitive function in noninsulin-dependent diabetics. J. Diabet. Complications, 2, 210-213.
42. Pipatpiboon, N., Pratchayasakul, W., Chattipakorn, N. & Chattipakorn, S.C. (2012) PPARgamma agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets. Endocrinology, 153, 329-338.
43. Porter, D.W., Kerr, B.D., Flatt, P.R., Holscher, C. & Gault, V.A. (2010) Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance. Diabetes Obes. Metab., 12, 891-899.
44. Pratchayasakul, W., Chattipakorn, N. & Chattipakorn, S.C. (2011a) Effects of estrogen in preventing neuronal insulin resistance in hippocampus of obese rats are different between genders. Life Sci., 89, 702-707.
45. Pratchayasakul, W., Kerdphoo, S., Petsophonsakul, P., Pongchaidecha, A., Chattipakorn, N. & Chattipakorn, S.C. (2011b) Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone. Life Sci., 88, 619-627.
46. Pratley, R.E. & Salsali, A. (2007) Inhibition of DPP-4: a new therapeutic approach for the treatment of type 2 diabetes. Curr. Med. Res. Opin., 23, 919-931.
47. Ranganath, L.R. (2008) Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1. J. Clin. Pathol., 61, 401-409.
48. Redondo, A., Trigo, M.V., Acitores, A., Valverde, I. & Villanueva-Penacarrillo, M.L. (2003) Cell signalling of the GLP-1 action in rat liver. Mol. Cell. Endocrinol., 204, 43-50.
49. Riant, E., Waget, A., Cogo, H., Arnal, J.F., Burcelin, R. & Gourdy, P. (2009) Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology, 150, 2109-2117.
50. Sasson, Z., Rasooly, Y., Bhesania, T. & Rasooly, I. (1993) Insulin resistance is an important determinant of left ventricular mass in the obese. Circulation, 88, 1431-1436.
51. Sato, K., Nakamura, A., Shirakawa, J., Muraoka, T., Togashi, Y., Shinoda, K., Orime, K., Kubota, N., Kadowaki, T. & Terauchi, Y. (2012) Impact of the dipeptidyl peptidase-4 inhibitor vildagliptin on glucose tolerance and beta-cell function and mass in insulin receptor substrate-2-knockout mice fed a high-fat diet. Endocrinology, 153, 1093-1102.
52. Thummasorn, S., Kumfu, S., Chattipakorn, S. & Chattipakorn, N. (2011) Granulocyte-colony stimulating factor attenuates mitochondrial dysfunction induced by oxidative stress in cardiac mitochondria. Mitochondrion, 11, 457-466.
53. Verspohl, E.J. (2009) Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors. Pharmacol. Ther., 124, 113-138.
54. Wang, C.H., Wang, C.C. & Wei, Y.H. (2010) Mitochondrial dysfunction in insulin insensitivity: implication of mitochondrial role in type 2 diabetes. Ann. NY Acad. Sci., 1201, 157-165.
55. Zakula, Z., Koricanac, G., Tepavcevic, S., Stojiljkovic, M., Milosavljevic, T. & Isenovic, E.R. (2011) Impairment of cardiac insulin signaling in fructose-fed ovariectomized female Wistar rats. Eur. J. Nutr., 50, 543-551.
56. Zhang, F., Ye, C., Li, G., Ding, W., Zhou, W., Zhu, H., Chen, G., Luo, T., Guang, M., Liu, Y., Zhang, D., Zheng, S., Yang, J., Gu, Y., Xie, X. & Luo, M. (2003) The rat model of type 2 diabetic mellitus and its glycometabolism characters. Exp. Anim., 52, 401-407.
57. Zhao, W., Chen, H., Xu, H., Moore, E., Meiri, N., Quon, M.J. & Alkon, D.L. (1999) Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J. Biol. Chem., 274, 34893-34902.